Share on StockTwits

Investment analysts at JMP Securities initiated coverage on shares of Loxo Oncology (NASDAQ:LOXO) in a note issued to investors on Tuesday, reports. The firm set an “outperform” rating on the stock.

Loxo Oncology (NASDAQ:LOXO) opened at 13.05 on Tuesday. Loxo Oncology has a one year low of $12.72 and a one year high of $13.42. The stock has a 50-day moving average of $13.04 and a 200-day moving average of $13.04. The company’s market cap is $208.0 million.

Loxo Oncology, Inc (NASDAQ:LOXO) develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations.

The Fly On The Wall

Receive News & Ratings for Loxo Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loxo Oncology Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.